Treatment successfully delivers drug across the blood-brain barrier directly to brain tumor in mice
- Glioblastoma currently has no cure. New treatments urgently needed
- Powerful drug is 1,400 times more potent than current treatment against the brain tumor
- Scientists applying to FDA for approval to test this novel treatment in patients with recurrent glioblastoma
One of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can’t be used in patients because of two problems. First, it can’t reach its target because it’s blocked by the blood-brain barrier, a microscopic structure that protects the brain from toxins in the blood. And the conventional formulation for this drug is toxic to the brain.
But now Northwestern Medicine scientists have used a novel technology for opening the blood-brain barrier with an implantable ultrasound, and have delivered the powerful drug to the tumor in mice. In a new paper, they report on their findings of extensive preclinical research.
The scientists also discovered brain toxicity for the conventional formulation for this drug – paclitaxel -to the brain was caused by the solution required to dissolve the drug (cremophor.) Scientists tested a new formulation of the drug that uses albumin as opposed to cremophor, and it was not harmful to the brain.
Opening of the blood-brain barrier with an ultrasound increased the concentrations of this paclitaxel in the brain by five-fold. The study also showed that the brain tumor-bearing mice live much longer when treated with the powerful cancer-fighting drug paclitaxel, and survival was even further extended when treated in combination with ultrasound to open the blood-brain barrier.
The study will be published Dec. 12 in Clinical Cancer Research, a journal of the American Association for Cancer Research.
In the laboratory, paclitaxel is much more potent than the currently used chemotherapy temozolomide. When paclitaxel was tested against the brain tumor in a dish outside an organism, a 1,400-fold lesser drug concentration was necessary to kill same number of tumor cells, compared to the conventional chemotherapy used for this cancer.
The scientists are now applying to the U.S. Food & Drug Administration to launch a clinical trial to test this concept of a new formulation of paclitaxel in combination with the novel ultrasound technology to open the blood-brain barrier in patients. The planned trial aims to determine if the treatment is safe, and if it prolongs survival of patients with brain cancer.
“Glioblastoma currently has no cure, and when the tumor recurs there are not many treatment options,” said the principal investigator for this study, Dr. Adam Sonabend, an assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician. “We urgently need effective new treatments.”
The ultrasound technology may have broader benefits. “This ultrasound technology now will enable us to use many agents established in other cancers for patients with brain tumors,” said co-investigator Roger Stupp, chief of neuro-oncology and the Paul C. Bucy Professor of Neurological Surgery at Feinberg.
Other clinical trials are testing ultrasound-based opening of the blood brain barrier with various chemotherapy agents, but none are using such a potent drug as paclitaxel.
How does it work?
The tiny ultrasound would be implanted during surgery into a window in the skull that does not contain bone. It is used in combination with microscopic gas bubbles injected into the blood at the same time the ultrasound begins. When the bubbles hit the sound waves, these vibrate and mechanically disrupt the blood-brain barrier. The opening is immediate, allowing penetration of the drug molecules. The blood-brain barrier opening is reversible and lasts for several hours after the sonication. The ultrasound emitter remains in the skull for repeated delivery of the drug.
Go deeper with Bing News on:
- Targeted drug combination shows unprecedented activity in some highly aggressive brain tumors
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a ...
- Adding Nivolumab to Standard Care Does Not Improve Survival in Glioblastoma
Adding nivolumab to the combination of radiotherapy and temozolomide does not appear to improve survival among patients with newly diagnosed glioblastoma with methylated or indeterminate MGMT promoter ...
- Repurposed Alzheimer’s medication provides new glioblastoma treatment
New research has identified that a medication previously prescribed for Alzheimer’s disease may work as an effective glioblastoma treatment.
- Former Escondido, San Diego police officer dies of brain cancer
A police motorcade ushered Brett Byler to his memorial service Tuesday in Vista; he was diagnosed with glioblastoma in early 2020 and died this month ...
- Drug designed for Alzheimer's disease may hold promise for treating glioblastoma
New Cleveland Clinic research has found that drugs originally designed to help treat Alzheimer's disease may hold promise for glioblastoma, the most common and lethal type of primary brain tumor. The ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- I had no idea I was pregnant until I saw my baby’s feet on an emergency ultrasound – I gave birth 15 minutes later
ONE woman had NO idea she was pregnant until she saw a pair of tiny feet on an ultrasound, mere minutes before birth. Kayla Nicole Simpson, an Indiana University student, was in labour but thought ...
- Global $456M Veterinary Ultrasound Market Insights and Growth Assessment to 2026
The "Veterinary Ultrasound Market by Type (2D, 3D-4D, Doppler), Product (Portable), Technology (Digital, Contrast Imaging), Animal Type (Small, Large), Application (Obstetrics, Cardiology, and ...
- MRI Guided & Focused Ultrasound Devices Market 2021 Analysis, Growth by Top Companies, Trends by Types and Application, Forecast Analysis To 2027
MRI Guided and Focused Ultrasound Devices Market ” Report provides industry a wide vision into current and developing growth outlines, end-user analysis, and other basic information that have been ...
- Diagnostic Ultrasound Devices Market 2021 Analysis and In-Depth Research on Market Dynamics, Trends, Emerging Growth Factors and Forecasts To 2027
Diagnostic Ultrasound Devices Market” report delivers a complete information of the industry including both production ...
- Anesthesia Color Ultrasound Market Qualitative Insights Key Enhancement & Share Analysis to 2026
Portland United States Big Market Research newly added a research report on the Anesthesia Color Ultrasound Market which represents a study for the period from 2021 to 2026 The research study provides ...